Consulte los últimos artículos sobre la enfermedad de von Willebrand
Última actualización: Viernes, 04 de julio de 2025Neuraxial anesthesia is used for pain management in surgical and nonsurgical settings. Spinal/epidural hematomas likely occur in between 1:10 000 and 1:200 000 procedures. Risk is believed to be greater...
Leer más
Von Willebrand disease (VWD) reflects the most common inherited bleeding disorder, arising from defects or deficiencies in the von Willebrand factor (VWF). VWD treatment mostly relies on the replacement...
Leer más
Acquired von Willebrand syndrome (AVWS) is a well-known complication of a monoclonal gammopathy with a potentially severe bleeding tendency. Treatment with von Willebrand factor (VWF)/factor VIII (FVIII)...
Leer más
Von Willebrand disease (VWD) type 2 arises from variants in von Willebrand factor (VWF) that disrupt its essential hemostatic functions. Per ISTH guidelines, it is classified as type 2A, 2B, 2M, and 2N based on the affected VWF roles.Objectives: This population-based study aims to uncover the genotype and laboratory phenotypes in type 2 VWD, providing insights into underlying genetics and genotype-phenotype associations....
Leer más
2 Current and emerging therapies as potential treatment for people with von Willebrand disease
Expert Review of Hematology 2024; 17(12): 917-333 Acquired von Willebrand syndrome secondary to monoclonal gammopathy: a single-center case series.
Therapeutic advances in hematology 2025 ; 16: 20406207251347235Refine su búsqueda de información científica
Búsqueda Avanzada ¿Necesita ayuda?